Rashtriya Chemicals and Fertilizers (RCF) reported a strong financial performance for FY 2025-26, with PAT rising 77.88% to Rs 429.81 crore on a 9.13% revenue growth. The company achieved record-breaking fertilizer sales and announced a final dividend of Rs 1.34 per share. However, shareholders should note the company's plan to raise up to Rs 1,500 crore via an FPO and Rs 1,100 crore through NCDs, alongside ongoing regulatory non-compliance issues regarding board composition.
Rashtriya Chemicals and Fertilizers Reports 78% Profit Growth
Revenue reached Rs 18,480.17 crore; Profit After Tax stood at Rs 429.81 crore.
Reader Takeaway: Strong operational volume growth and margins drive profits, but FPO dilution and board governance gaps pose risks.
What just happened
Rashtriya Chemicals and Fertilizers (RCF) released its annual performance report for FY 2025-26, highlighting a significant surge in profitability. While revenue grew 9.13% to Rs 18,480.17 crore, the company's bottom line jumped 77.88% to Rs 429.81 crore. This growth was fueled by record sales volumes in fertilizers, including total fertilizer sales of 37.60 LMT.
Why this matters
The company is signaling a major capital expansion phase. The board has approved a fundraising plan involving an FPO of up to Rs 1,500 crore and the issuance of NCDs worth Rs 1,100 crore. These funds are earmarked for upcoming projects like the 1200 MTPD NPK plant at Thal, expected to be operational by March 2027, and a new 300 MTPD Phosphoric Acid plant.
Governance Update
The Secretarial Audit Report highlighted persistent non-compliance with SEBI (LODR) regulations regarding the composition of the Board of Directors and key committees. As a Government of India undertaking, RCF cited that board appointments are centralized under the administrative ministry. Investors should monitor this, as these governance gaps remain a point of concern for regulatory adherence.
Risks to watch
Investors should be wary of the potential equity dilution from the proposed Rs 1,500 crore FPO. Additionally, the regulatory delays in appointing the required number of independent directors could lead to friction with market watchdogs. Execution risk regarding the multi-year capacity expansion projects at Thal also remains a key factor for long-term valuation.
What to track next
Watch for the specific timeline of the FPO launch and further government updates on board restructuring. Continued tracking of NPK plant construction milestones will be essential to gauge future revenue growth capacity.